Skip to content
Screener

MiMedx Group MDXG Current Debt

Current Debt at other companies

IAR
Integra LifeSciencesIART
$53.28M+37.5%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$859K-29.4%
Solventum logo
SolventumSOLV
$506M
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$0
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$125K-84.3%
Enovis logo
EnovisENOV
$37.39M+86.7%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemJune 30,2026December 31,2025
Total assets$280,998$342,653
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long term debt$1,500$1,500
Accounts payable8,29314,528
Accrued compensation13,17531,065
Accrued expenses11,14011,383
Other current liabilities4,3905,790

Item 1. Financial Statements

FAQ

What is MiMedx Group's current debt?
MiMedx Group (MDXG) reported current debt of $1.5M in Q2 2026.
How has MiMedx Group's current debt changed year-over-year?
MiMedx Group's current debt increased by 20.0% year-over-year, from $1.25M to $1.5M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Ask your AI about MiMedx Group's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude